Associate Professor of Internal Medicine
Department of Internal Medicine
1500 E. Medical Center Drive
Ann Arbor, MI 48109
1500 E. Medical Center Drive
Ann Arbor, MI 48109
Available to mentor
Vaibhav Sahai
Clinical Associate Professor
-
Chief FellowNorthwestern University, Internal Medicine - Hematology and Oncology, 2013
-
FellowNorthwestern University, Internal Medicine - Hematology and Oncology, 2012
-
ResidentUniversity of Pittsburgh Medical Center, Internal Medicine, 2010
-
Postdoctoral FellowHarvard Medical School, Radiology, 2007
-
MSHarvard School of Public Health, 677 Huntington Avenue, 2006
-
MB BSGovernment Medical College, One Circular Road, 2004
-
Center MemberPrecision Health Initiative
-
Center MemberRogel Cancer Center
-
Vogel A, Sahai V, Hollebecque A, Vaccaro GM, Melisi D, Al Rajabi RM, Paulson AS, Borad MJ, Gallinson D, Murphy AG, Oh D-Y, Dotan E, Catenacci DV, Van Cutsem E, Lihou CF, Zhen H, Veronese ML, Abou-Alfa GK. ESMO Open, 2024 Jun; 9 (6): 103488Journal ArticleAn open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202.
DOI:10.1016/j.esmoop.2024.103488 PMID: 38838500 -
Carpenter ES, Kadiyala P, Elhossiny AM, Kemp SB, Li J, Steele NG, Nicolle R, Nwosu ZC, Freeman J, Dai H, Paglia D, Du W, Donahue K, Morales J, Medina-Cabrera PI, Bonilla ME, Harris L, The S, Gunchick V, Peterson N, Brown K, Mattea M, Espinoza CE, McGue J, Kabala SM, Baliira RK, Renollet NM, Mooney AG, Liu J, Bhalla S, Farida JP, Ko C, Machicado JD, Kwon RS, Wamsteker E-J, Schulman A, Anderson MA, Law R, Prabhu A, Coulombe PA, Rao A, Frankel TL, Bednar F, Shi J, Sahai V, Pasca Di Magliano M. Clin Cancer Res, 2024 Jun 3; 30 (11): 2497 - 2513.Journal ArticleKRT17high/CXCL8+ Tumor Cells Display Both Classical and Basal Features and Regulate Myeloid Infiltration in the Pancreatic Cancer Microenvironment.
DOI:10.1158/1078-0432.CCR-23-1421 PMID: 37851080 -
Cannon TL, Rothe M, Mangat PK, Garrett-Mayer E, Chiu VK, Hwang J, Vijayvergia N, Alese OB, Dib EG, Duvivier HL, Klute KA, Sahai V, Ahn ER, Bedano P, Behl D, Sinclair S, Thota R, Urba WJ, Yang ES, Grantham GN, Hinshaw DC, Gregory A, Halabi S, Schilsky RL. J Clin Oncol, 2024 May 15; JCO2302078Journal ArticlePertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With ERBB2/3 Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.
DOI:10.1200/JCO.23.02078 PMID: 38748939 -
Elhossiny A, Kadiyala P, Liu J, Peterson N, Kwon R, Machicado JD, Schulman AR, Wamsteker E-J, Philips GM, Hogenson T, Shi J, Frankel T, Sahai V, Truty MJ, Fernandez-Zapico ME, Bednar F, Di Magliano MP, Carpenter E. Gastroenterology, 2024 May; 166 (5): s - 8.Journal Article24 TRACING PANCREATIC TUMOR EVOLUTION THROUGH SPACE AND TIME
DOI:10.1016/s0016-5085(24)00513-4 -
2024 Apr 10;PresentationEnhancing anti-tumor immune responses in pancreatic cancer with PARP inhibitors and radiotherapy in the lab and clinic
-
Enzler T, Nguyen A, Misleh J, Cline VJ, Johns M, Shumway N, Paulson S, Siegel R, Larson T, Messersmith W, Richards D, Chaves J, Pierce E, Zalupski M, Sahai V, Orr D, Ruste SA, Haun A, Kawabe T. Eur J Cancer, 2024 Apr; 201: 113950Journal ArticleA multicenter, randomized phase 2 study to establish combinations of CBP501, cisplatin and nivolumab for ≥3rd-line treatment of patients with advanced pancreatic adenocarcinoma.
DOI:10.1016/j.ejca.2024.113950 PMID: 38422585 -
2024 Apr;PresentationHot Topics on Cholangiocarcinoma
-
Cheng C, Hu J, Mannan R, Bhattacharyya R, Rossiter NJ, Magnuson B, Wisniewski JP, Zheng Y, Xiao L, Li C, Awad D, He T, Bao Y, Zhang Y, Cao X, Wang Z, Mehra R, Morlacchi P, Sahai V, di Magliano MP, Shah YM, Ding K, Qiao Y, Lyssiotis CA, Chinnaiyan AM. 2024 Mar 20;PreprintTargeting PIKfyve-driven lipid homeostasis as a metabolic vulnerability in pancreatic cancer.
DOI:10.1101/2024.03.18.585580 PMID: 38562800